NPRHealth
Trump administration opens door to peptide compounding
The Trump administration will let small compounding pharmacies make six peptides that lack Food and Drug Administration approval. The move could widen access to popular products, but pharmacies may still struggle to meet demand.
This card is an AI-assisted summary of reporting published by NPR. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.